In this process, interferon-γ (IFNγ) derived from activated CD8+ T cells has been shown to defer the expression of SLC3A2 and SLC7A11, inhibiting tumor cell cystine import and sensitizing tumor cells to ferroptosis. Here, SLC7A11 is linked to neoplasm.